Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 22 studies | 36% ± 9% | |
CD4-positive, alpha-beta T cell | 21 studies | 24% ± 9% | |
T cell | 9 studies | 25% ± 5% | |
CD4-positive, alpha-beta memory T cell | 7 studies | 26% ± 9% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 7 studies | 20% ± 5% | |
T follicular helper cell | 7 studies | 39% ± 15% | |
CD8-positive, alpha-beta T cell | 5 studies | 20% ± 3% | |
CD4-positive helper T cell | 4 studies | 23% ± 5% | |
effector memory CD4-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
T-helper 17 cell | 3 studies | 28% ± 9% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lymph node | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 178.12 | 576 / 578 | 81% | 3.37 | 935 / 1155 |
stomach | 70% | 28.15 | 253 / 359 | 69% | 2.48 | 197 / 286 |
thymus | 79% | 62.21 | 519 / 653 | 48% | 3.02 | 288 / 605 |
intestine | 60% | 90.09 | 579 / 966 | 64% | 1.92 | 338 / 527 |
breast | 56% | 19.99 | 255 / 459 | 63% | 3.02 | 701 / 1118 |
bladder | 52% | 27.62 | 11 / 21 | 57% | 2.13 | 289 / 504 |
esophagus | 33% | 13.88 | 478 / 1445 | 70% | 2.82 | 129 / 183 |
uterus | 41% | 9.98 | 69 / 170 | 62% | 2.48 | 284 / 459 |
spleen | 100% | 255.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.23 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 16.56 | 27 / 29 |
skin | 31% | 8.70 | 554 / 1809 | 62% | 3.44 | 292 / 472 |
prostate | 65% | 26.28 | 159 / 245 | 27% | 0.72 | 135 / 502 |
kidney | 47% | 31.90 | 42 / 89 | 41% | 1.38 | 373 / 901 |
peripheral blood | 88% | 224.50 | 819 / 929 | 0% | 0 | 0 / 0 |
adipose | 72% | 36.07 | 871 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 9% | 1.43 | 28 / 328 | 58% | 1.97 | 104 / 178 |
liver | 42% | 12.57 | 95 / 226 | 23% | 0.64 | 92 / 406 |
ovary | 18% | 4.39 | 33 / 180 | 35% | 0.84 | 149 / 430 |
blood vessel | 40% | 16.76 | 532 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 14% | 2.88 | 35 / 258 | 4% | 0.07 | 9 / 230 |
heart | 16% | 4.86 | 139 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.23 | 8 / 80 |
brain | 3% | 0.71 | 83 / 2642 | 4% | 0.08 | 25 / 705 |
muscle | 2% | 0.57 | 16 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031295 | Biological process | T cell costimulation |
GO_0006955 | Biological process | immune response |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0002517 | Biological process | T cell tolerance induction |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | ICOS |
Protein name | Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278) Inducible T-cell costimulator |
Synonyms | AILIM hCG_1642889 |
Description | FUNCTION: Enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells. Essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens. Does not up-regulate the production of interleukin-2, but superinduces the synthesis of interleukin-10. Prevents the apoptosis of pre-activated T-cells. Plays a critical role in CD40-mediated class switching of immunoglobin isotypes (By similarity). . FUNCTION: Enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells. Essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens. Does not up-regulate the production of interleukin-2, but superinduces the synthesis of interleukin-10. Prevents the apoptosis of pre-activated T-cells. Plays a critical role in CD40-mediated class switching of immunoglobin isotypes. . |
Accessions | Q9Y6W8 Q53QY6 ENST00000316386.11 [Q9Y6W8-1] ENST00000435193.1 [Q9Y6W8-2] |